Cargando…
A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease
The mucopolysaccharidoses (MPS), Pompe Disease (PD), and Krabbe disease (KD) are inherited conditions known as lysosomal storage disorders (LSDs) The resulting enzyme deficiencies give rise to progressive symptoms. The United States Department of Health and Human Services’ Recommended Uniform Screen...
Autores principales: | Jalal, Kabir, Carter, Randy L., Barczykowski, Amy, Tomatsu, Shunji, Langan, Thomas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680456/ https://www.ncbi.nlm.nih.gov/pubmed/36412587 http://dx.doi.org/10.3390/ijns8040061 |
Ejemplares similares
-
Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
por: Langan, Thomas J., et al.
Publicado: (2020) -
Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy
por: Langan, Thomas J., et al.
Publicado: (2019) -
The Impact of Post-Analytical Tools on New York Screening for Krabbe Disease and Pompe Disease
por: Martin, Monica M., et al.
Publicado: (2020) -
Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020) -
Newborn Screening for Krabbe Disease—Illinois Experience: Role of Psychosine in Diagnosis of the Disease
por: Basheeruddin, Khaja, et al.
Publicado: (2021)